Signal Genetics (Nasdaq: SGNL) 31.6% HIGHER; announced the signing of a Master Service Agreement (MSA) with a leading biopharmaceutical company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE